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Epidemiologic studies have suggested that hypertri-
glyceridemia is an independent risk factor for coronary
artery disease (CAD) [1,2]. Based on the 1993–1996
National Nutrition Survey in Taiwan [3], the prevalence
of hypertriglyceridemia in aboriginal adults (>19 years)
was the highest compared with other non-aboriginal
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The prevalence of hypertriglyceridemia, considered to be an independent risk factor for the devel-
opment of cardiovascular disease, is high in Taiwanese aborigines. This study was undertaken 
to examine the effect of the -1131T > C polymorphism in the apolipoprotein A5 gene on serum
triglyceride levels in female Taiwanese aborigines. This was a cross-sectional study, and a total of
316 unrelated female Taiwanese aborigines were genotyped at the -1131T > C polymorphism in
apolipoprotein A5 using the polymerase chain reaction-restriction fragment length polymorphism
method. Serum triglyceride ≥ 150 mg/dL was defined as the hypertriglyceridemia group and
triglyceride < 150 mg/dL was considered to be the control group. The frequency of the minor C
allele was significantly higher in the hypertriglyceridemia group (0.53) than in the control group
(0.35) (p < 0.001). The frequency of this rare allele was comparable to that in Japanese and Han
Chinese, but was higher than that in Caucasians. In a multiple logistic model adjusted for possible
confounders, C allele-containing variants were independently associated with greater risks (CT
genotype: OR = 3.28, 95% CI = 1.43–7.56; CC genotype: OR = 5.86, 95% CI = 2.15–15.99) of hyper-
triglyceridemia than the TT genotype (p < 0.01), notably with the CC homozygote exhibiting the
greatest risks. The genotype polymorphisms were also associated with serum triglyceride concen-
trations in a linear fashion (for trend, p<0.05). Our results indicate that the -1131T>C polymorphism
of the Apo A5 gene influences serum triglyceride levels in female Taiwanese aborigines, and that
differences exist in the frequency of the C allele among people of various ethnicities.
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groups examined. A recent report also demonstrated
that standardized mortality rates for heart diseases
(1.1–2.4) in aborigines were significantly higher than
those in non-aborigines in Taiwan during the period
1981–1990 [4].
Recently, Pennacchio et al [5] identified apolipopro-
tein AV (Apo A5), a new protein that may exercise an
effect on triglyceride metabolism. It is located on chro-
mosome 11q23, about 27 kb upstream of the well-
characterized Apo A1/Apo C3/Apo A4 gene cluster
[6]. In Apo A5 (-/-) knockout mice, serum triglyceride
levels are four times higher than those in normal mice,
whereas transgenic mice expressing human Apo A5
have triglyceride levels that are only approximately
one third of the normal level [5,7]. In humans, several
single nucleotide polymorphisms (SNPs) comprising
three common haplotypes (Apo A5*1, Apo A5*2, and
Apo A5*3) have been identified in Caucasians [8]. 
A minor haplotype of Apo A5 (Apo A5*2), defined 
by three polymorphisms (c. 1259T > C, IVS3 + 476G >
A and -1131T > C), was associated with a 20–30%
increase in serum levels of triglycerides in 500 unre-
lated Caucasians [5]. The -1131T > C variant, con-
firmed to be a marker for the haplotype A5*2, showed
a significant association with elevated triglyceride
levels in different ethnic groups including Chinese,
Japanese children, and Caucasians [8–12]. Furthermore,
studies also demonstrated that serum Apo A5 levels
were significantly negatively correlated with serum
triglyceride concentrations and positively related to
HDL-cholesterol levels in the Chinese population, and
this association was only observed in female subjects
[13]. The impact of gender on the association between
Apo A5 and blood triglyceride levels was also sup-
ported by previous studies by Ishihara et al [14]. The
above evidence suggests a role for Apo A5 in hyper-
triglyceridemia, and both genetic ethnicities and gender
differences may, in part, contribute to the development
of hypertriglyceridemia.
Taiwanese aborigines are genetically different from
Han Chinese [15,16] and represent only about 2% of
the population in Taiwan. They rarely mix with Han
Chinese and reside in isolated mountainous areas.
Recent mitochondrial genetic analysis suggests that a
link exists between Taiwanese aborigines and Poly-
nesians [15,16]. Considering the high prevalence of
hypertriglyceridemia in Taiwanese aborigines and the
fact that there have been no studies investigating the
effect of the Apo A5 -1131T > C polymorphic variant
on levels of triglyceridemia, the current study was
undertaken to examine the association between the
Apo A5 -1131T > C variant and elevated triglycerides
in a cross-sectional setting. Because a correlation be-
tween Apo A5 and blood triglyceride levels was found
only in females, we selected female aborigines for the
investigation.
MATERIALS AND METHODS
Study design and subjects
From August 2003 to February 2004, community
health examinations were performed in the aboriginal
community of Majia Township, in southern Taiwan.
Parental origins were the basis for determining a par-
ticipant’s aboriginal tribal classification, and only sub-
jects whose parents originated from the same tribe
were included, in order to reduce genetic variation.
The study comprised a total of 316 unrelated female
Taiwanese aborigines of the Paiwan and Rukei tribes
after excluding non-aborigines and mixed aborigines.
Hypertriglyceridemia was defined as serum triglyc-
eride ≥ 150 mg/dL according to the criteria set by the
National Cholesterol Education Program [17], and
those with serum triglyceride levels <150 mg/dL were
control subjects. All subjects gave written informed
consent and the study protocol was approved by the
Human Ethical Committee of Kaohsiung Medical
University.
Demographic and clinical measures
Anthropometric measurements were performed to
obtain weight, height, waist circumference and hip
circumference. Body mass index (BMI) was calculated
as the weight in kilograms divided by the square height
in meters (kg/m2). History taking included informa-
tion with regard to history of chronic diseases, par-
ents’ tribal background, alcohol consumption, betel
quid chewing, and tobacco use (cigarette smoking).
Dietary habits for consuming various food groups
were obtained using a food frequency questionnaire
conducted by trained interviewers.
Venous blood specimens were collected after an 8-
to 12-hour fast. Serum specimens for routine clinical
blood measurements were stored at 4°C and the ana-
lyses were performed within 2 days of serum collection.
These measurements included serum triglycerides,
cholesterol, aspartate aminotransferase (AST), alanine
aminotransferase (ALT), creatinine and uric acid, and
were obtained using an auto-analyzer (Beckman LX-
20, Palo Alto, CA, USA). DNA was extracted from
white blood cells using a commercial Puregene kit
(Gentra Systems Inc., Minneapolis, MN, USA), and
the DNA specimens were then stored at −20°C until
DNA genotyping.
Apolipoprotein A5 genotyping
DNA samples were subjected to amplification by PCR
in an automatic thermal cycler. The T/C polymorphism
in the 5’ region of the Apo A5 gene was genotyped by
the PCR-RFLP method using MseI restriction endo-
nuclease as described previously [5]. The following
oligonucleotides were used for amplification: forward,
5’-CCCCAGGAACTGGAGCGAAATT-3’; reverse, 5’-
AAAGACCTGTTGGAGGCTAT-3’. Amplification of
the MseI site of Apo A5 was performed using the fol-
lowing program: denaturation at 95°C for 5 minutes,
followed by 95°C for 30 seconds, 55°C for 30 seconds
and 72°C for 30 seconds, followed by a further incuba-
tion at 72°C for 7 minutes.
Statistical analysis
SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) for
Windows was used for all statistical analyses. One-
way analysis of variance or the Student’s t test was
employed to analyze differences in continuous vari-
ables, while the χ2 test or Fisher’s exact test (if n ≤ 5)
was used to analyze the proportions of categorical
variables. The allelic distribution of SNP in the control
or in the hypertriglyceridemia group was verified
using Hardy-Weinberg equilibrium. Multiple logistic
regression analysis was used to adjust for potential
confounders, and to analyze the independent associ-
ation between Apo A5 -1131T > C polymorphism and
hypertriglyceridemia; p < 0.05 was considered signifi-
cantly different.
RESULTS
The clinical characteristics and lifestyle-related expo-
sure of the studied subjects are listed in Table 1. There
were no differences in mean age between hypertriglyc-
eridemia and control groups. With regard to anthro-
pometric parameters, significantly higher BMI and
waist/hip ratio were found in hypertriglyceridemia
subjects. Fasting serum cholesterol, triglyceride, AST,
ALT, and uric acid levels were significantly higher (p<
0.05) in hypertriglyceridemia subjects than control sub-
jects. By contrast, blood pressure and serum creatinine
were similar between the two groups. Distributions
of education levels, tribal background and consump-
tion frequencies of various food groups (cereal, fruits,
vegetables, seafood, soy-based foods, egg products,
sweetened drinks, and desserts) were all similar be-
tween the two groups. On the other hand, distributions
of alcohol use, smoking, and betel quid chewing were
significantly different between hypertriglyceridemia
and control groups (p < 0.05).
The Apo A5 -1131T > C genotype and allelic distri-
butions are presented in Table 2. We found that the
Apo A5 -1131T > C polymorphisms were in Hardy-
Weinberg equilibrium. The frequencies of TT, TC and
CC genotypes of Apo A5 -1131T>C were 41.3% (n=99),
46.3% (n = 111) and 12.5% (n = 30), respectively, in the
control group, and 19.7% (n = 15), 53.9% (n = 41) and
26.3% (n=20), respectively, in the hypertriglyceridemia
group (p<0.05). C allele frequencies were 0.533 (n=81)
in the hypertriglyceridemia group and 0.356 (n = 171)
in the control group (p < 0.001).
The profile of triglyceride levels among individuals
with TT, CT and CC genotypes of Apo A5 -1131T > C
is shown in Table 3. Serum triglyceride levels were
positively correlated with TT, CT and CC genotypes
in a linear trend (for analysis of variance, p < 0.05; for
trend, p<0.05). Profiles of BMI and other clinical param-
eters including AST, cholesterol, uric acid, creatinine,
and blood pressure, were all similar among the three
genotypes (p > 0.05).
Multivariable logistic regression analysis of the rela-
tions between Apo A5 -1131T > C and hypertriglyceri-
demia is presented in Table 4. After adjustment for age
and tribal background, subjects carrying Apo A5 -1131C
minor allele showed higher risks (CT genotype: OR =
2.53, 95% CI = 1.31–4.88; CC genotype: OR = 4.58, 95%
CI=2.07–10.10) of hypertriglyceridemia compared with
subjects with a TT genotype (p < 0.01). After adjust-
ment for age, tribal background and all other possible
confounding factors (education levels, BMI, AST, ALT,
cholesterol, uric acid, smoking, drinking, and betel
chewing), C allele carriers were significantly associated
with higher risks (p<0.01) of hypertriglyceridemic sta-
tus (CT genotype: OR = 3.28, 95% CI = 1.43–7.56; CC
genotype: OR = 5.86, 95% CI = 2.15–15.99). Besides the
confounding factors (education levels, BMI, AST, ALT,
cholesterol, uric acid, smoking, drinking, and betel
Apolipoprotein A5 -1131T > C polymorphism
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Table 1. Clinical characteristics in hypertriglyceridemic and control subjects*
Control† (n = 240) Hypertriglyceridemia† (n = 76) p‡
Clinical parameters§
Age (yr) 60.98 ± 13.58 59.57 ± 10.15 NS
BMI (kg/m2) 27.26 ± 5.29 29.44 ± 4.60 < 0.01
Waist/hip ratio 0.86 ± 0.11 0.90 ± 0.14 < 0.05
DBP (mmHg) 132.35 ± 21.38 136.23 ± 22.83 NS
SBP (mmHg) 82.40 ± 12.30 83.60 ± 13.31 NS
Triglyceride (mg/dL) 85.73 ± 28.99 233.74 ± 100.63 < 0.01
Cholesterol (mg/dL) 182.07 ± 35.82 204.68 ± 45.12 < 0.01
Uric acid (mg/dL) 6.09 ± 1.57 6.75 ± 1.55 < 0.02
AST (mg/dL) 22.42 ± 6.78 25.66 ± 13.53 < 0.01
ALT (mg/dL) 15.85 ± 6.78 20.47 ± 12.32 < 0.01
Creatinine (mg/dL) 0.96 ± 0.23 0.96 ± 0.18 NS
Lifestyle/dietary habits§
Smoking 32 (20.9) 29 (43.3) 0.001
Drinking 76 (50.0) 47 (74.6) 0.001
Betel nut chewing 55 (35.3) 43 (64.2) < 0.001
Cereal
≤ 8 exchanges/d 95 (55.6) 37 (49.3) NS
12 exchanges/d 49 (28.7) 22 (29.3)
≥ 16 exchanges/d 27 (15.8) 16 (21.3)
Fruit
< 2 times/wk 96 (57.5) 42 (55.3) NS
3–6 times/wk 54 (32.3) 31 (40.8)
≥ 1 times/d 17 (10.2) 3 (3.9)
Vegetables
≤ 2 exchanges/d 129 (75.4) 51 (68.0) NS
> 2 exchange/d 42 (24.6) 24 (32.0)
Seafood
< 2 times/wk 99 (41.8) 30 (40.0) NS
3–6 times/wk 115 (48.5) 40 (53.3)
≥ 1 times/d 23 (9.7) 5 (6.7)
Soy-based food
< 2 times/wk 119 (50.4) 27 (36.5) NS
3–6 times/wk 106 (44.9) 44 (59.5)
≥ 1 times/d 11 (4.7) 3 (4.1)
Egg products
< 2 times/wk 104 (44.3) 25 (33.3) NS
3–6 times/wk 117 (49.8) 47 (62.7)
≥ 1 times/d 14 (6.0) 3 (4.0)
Sweetened drinks
< 2 times/wk 113 (56.6) 43 (58.1) NS
3–6 times/wk 82 (34.9) 26 (35.1)
≥ 1 times/d 20 (8.5) 5 (6.8)
Desserts
< 2 times/wk 103 (62.8) 50 (65.8) NS
3–6 times/wk 53 (32.3) 22 (28.9)
≥ 1 times/d 8 (4.9) 4 (5.3)
*Data expressed as mean ± standard deviation or n (%); †serum triglyceride < 150 mg/dL in control group and ≥ 150 mg/dL in hyper-
triglyceridemic group; ‡t test used to determine differences between the two groups and p < 0.05 is considered significantly different;
§there were 3–7 data missing in clinical parameters and 70–76 data missing in lifestyle/dietary habits; exchange was used to estimate
portion of foods. NS = not significantly different; BMI = body mass index; DBP = diastolic blood pressure; SBP = systolic blood pressure;
AST = aspartate aminotransferase; ALT = alanine aminotransferase.
Apolipoprotein A5 -1131T > C polymorphism
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Table 2. Distribution of -1131T>C polymorphism of Apolipoprotein A5 between control and hypertriglyceridemic subjects*
Control† (n = 240) Hypertriglyceridemia† (n = 76) Total (n = 316)
-1131T > C genotype
TT 99 (41.3) 15 (19.7) 114 (36.1)
CT 111 (46.3) 41 (53.9) 152 (48.1)
CC 30 (12.5) 20 (26.3) 50 (15.8)
χ2 15.079
p‡ 0.001
-1131T > C allele
T allele 309 (64.4) 71 (46.7) 380 (60.1)
C allele 171 (35.6) 81 (53.3) 252 (39.8)
χ2 15.025
p§ <0.001
*Data expressed as n (%); †serum triglyceride < 150 mg/dL in control group and ≥ 150 mg/dL in hypertriglyceridemic group; ‡χ2 test
used to test differences in genotype distribution between control and hypertriglyceridemic groups, p < 0.05 is considered significantly
different; §χ2 test used to test differences in allele distribution between control and hypertriglyceridemic groups, p < 0.05 is considered
significantly different.
Table 3. Anthropometric and clinical parameters among -1131T > C genotypes of Apolipoprotein A5*†
TT CT CC p‡
BMI (kg/m2) 28.21 ± 5.30 27.79 ± 5.02 26.73 ± 5.21 NS
Waist/hip ratio 0.88 ± 0.11 0.87 ± 0.11 0.86 ± 0.14 NS
DBP (mmHg) 130.27 ± 19.49 135.88 ± 23.48 132.50 ± 20.82 NS
SBP (mmHg) 81.44 ± 11.36 83.18 ± 13.51 83.98 ± 12.14 NS
Triglyceride (mg/dL) 101.39 ± 63.94 126.15 ± 87.35 152.12 ± 102.44 0.001
Cholesterol (mg/dL) 187.25 ± 36.65 187.66 ± 35.83 187.64 ± 54.08 NS
Uric acid (mg/dL) 6.31 ± 1.61 6.16 ± 1.55 6.40 ± 1.67 NS
AST (mg/dL) 21.61 ± 5.34 24.11 ± 10.99 24.04 ± 8.39 NS
ALT (mg/dL) 15.49 ± 5.89 18.17 ± 10.51 16.68 ± 7.19 0.042
Creatinine (mg/dL) 0.98 ± 0.20 0.95 ± 0.21 0.96 ± 0.28 NS
*Data expressed as mean ± standard deviation; †there were 3–7 missing data in some variables; ‡ANOVA used to determine the differ-
ences among TT, CT and CC genotypes, p < 0.05 is considered significantly different. BMI = body mass index; DBP = diastolic blood
pressure; SBP = systolic blood pressure; AST = aspartate aminotransferase; ALT = alanine aminotransferase; NS = not significantly
different.
Table 4. Multiple logistic regression analysis for the association between -1131T > C of Apolipoprotein A5 and hyper-
triglyceridemia*
Model 1† Model 2‡ Model 3§
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Apo A5 -1131T > C 1 1 1
CT vs. TT 2.53 (1.31–4.88) 0.005 3.28 (1.43–7.56) 0.005 4.51 (1.71–11.96) 0.002
CC vs. TT 4.58 (2.07–10.10) 0.000 5.86 (2.15–15.99) 0.001 8.05 (2.57–25.21) < 0.001
*Serum triglyceride < 150 mg/dL in control group and ≥ 150 mg/dL in hypertriglyceridemic group, and multiple logistic regression
was used to analyze the association and p < 0.05 is considered significantly different; †Model 1 is adjusted for age and tribal back-
ground; ‡Model 2 is adjusted for age, tribal background, education, body mass index, fasting serum aspartate aminotransferase, alanine
aminotransferase, cholesterol, uric acid, cigarette smoking, betel quid chewing and alcohol consumption; §Model 3 is adjusted for
age, tribal background, education, body mass index, fasting serum aspartate aminotransferase, alanine aminotransferase, cholesterol,
uric acid, cigarette smoking, betel quid chewing and alcohol consumption, habits of consuming various food groups (cereal, fruit,
vegetables, seafood, soy-based products, egg products, sweetened drinks, desserts).
chewing) adjusted for in Model 2, we also adjusted for
all dietary factors (consumption frequencies of cereal,
fruits, milk, sweetened drinks, desserts, vegetable,
meat, fish/seafood, soy products). The multivariable
logistic regression analysis (Model 3) consistently re-
vealed that subjects carrying the -1131C minor allele
(CT genotype: OR = 4.51, 95% CI = 1.71–11.96; CC
genotype: OR = 8.05, 95% CI = 2.57–25.21) had greater
risks of hypertriglyceridemia.
DISCUSSION
Of the 316 subjects genotyped, the frequencies of 
the C minor allele at Apo A5 -1131T > C were 0.356 
in female aborigines with normal serum triglyceride
levels and 0.533 in hypertriglyceridemic aborigines.
Several studies have investigated the frequency of
the C minor allele in different ethnic groups. In gen-
eral, the frequency was less than 10% for Caucasians
(0.08) [5], and approximately 30–35% for Japanese
(0.34) [10] and Han Chinese (0.30) [18,19]. Taiwanese
aborigines are genetically different from Han Chinese
and recent mitochondrial DNA analysis evidence dem-
onstrates that there is a link between Taiwanese ab-
origines and Polynesians [15]. Thus, the results of the
current investigation and previous reports [5,10,18,19]
demonstrate that the frequency of the C minor allele of
Apo A5 -1131C > T in Taiwanese aborigines is in line
with Asian populations, and is different from that in
Caucasians. Unlike many genetic association studies,
we only chose aborigines with the same parental tribal
ground, so this homogenous ethnic group avoids false-
positive findings due to potential confounding effects
derived from different ethnicities.
In the current study, analysis by a multivariate-
adjusted model indicated that the -1131T>C polymor-
phism of the Apo A5 gene is independently associated
with risks of hypertriglyceridemia, and that serum
triglyceride concentrations increase accordingly among
subjects with TT, TC and CC genotypes (for trend,
p < 0.05). Our analysis showed that, after adjusting for
possible confounders, individuals with a CC genotype
exhibited a 5.86-fold increase in the risk of development
of hypertriglyceridemia (CC genotype: OR = 5.86, 95%
CI = 2.15–15.99) and that individuals with a CT geno-
type only had a 3.28-fold increase in risk (CT genotype:
OR = 3.28, 95% CI = 1.43–7.56) compared with individ-
uals with a TT genotype. Notably, CC homozygotes
exhibited the greatest risks of hypertriglyceridemia
among individuals with TT, TC and CC genotypes.
Serum triglyceride levels were also influenced by 
the presence of some dietary factors, including con-
sumption of alcohol and carbohydrate-rich foods [20].
Among our female Taiwanese aborigines, we found
no significant differences in habits of consumption 
of various food groups between control and hyper-
triglyceridemic subjects. Moreover, adding all other
confounders into the final logistic model did not change
the results, further indicating that the influence of the
-1131T>C polymorphism on developing hypertriglyc-
eridemia is possibly independent of those variables.
The results of the current study indicate that sub-
jects carrying the C minor allele show augmentation
of blood triglyceride levels. Clinical studies in differ-
ent ethnic populations have shown that variations in
-1131T > C of the Apo A5 gene are strongly associated
with elevated triglyceride levels; studies conducted in
Japanese children [11] or adults without cardiovascular
diseases were highly significant (p < 0.001) [10,18,19].
As shown in adult studies, subjects carrying CT and
CC genotypes had triglyceride levels that were approx-
imately 10–25% and 14–80% higher, respectively, than
those in subjects with a TT genotype [10,18,19]. In the
current study, we found that the serum triglyceride
levels in C allele carriers among female Taiwanese
aborigines were 24–50% higher (Table 3). In contrast to
the results found in Japanese and Chinese [10,18,19],
this association was not significant in a population-
based Spanish control group, but was only found in
subjects with familial combined hyperlipidemia [21].
Thus, the above evidence implies that the impact of
this variant in the Apo A5 on hypertriglyceridemia can
differ among people of different ethnicities.
Mounting evidence from a number of studies has
supported an independent association between hy-
pertriglyceridemia and coronary artery disease [2].
Previous investigations also found that -1131C is sig-
nificantly associated with other traditional cardio-
vascular disease risk factors, which include reduced
HDL [10] and increased LDL particle size [22]. The
clinical significance of possessing this allele was sub-
sequently found in some case-control studies, that
showed approximately a two-fold increase in the fre-
quency of this allele in patient groups with coronary
heart and peripheral vascular disease, compared with
control groups [19,23,24]. Thus, the -1131T > C poly-
morphism in Apo A5 is considered to be a risk factor
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not only for hypertriglyceridemia, but also for cardio-
vascular diseases. Since approximately 40% of female
Taiwanese aborigines carry the rare C allele, this allele
might have a significant impact on public health issues.
The biochemical basis for the association of the 
-1131T > C polymorphism in the Apo A5 gene with
triglyceride metabolism or with the development of
cardiovascular disease has yet to be established. As 
-1131C > T is located in the promoter region, it is plau-
sible that the -1131C > T variant has a direct effect on
expression of the Apo A5 gene. Human studies show
that subjects possessing the -1131C minor allele had
impaired clearance of postprandial triglycerol-rich
lipoproteins. This has been postulated to be related to
the reduction in lipoprotein lipase-mediated clearance
attributed to decreases in Apo A5 protein activity [25].
Furthermore, animal studies have demonstrated that
an Apo A5 transgene leads to a 65% reduction in triglyc-
eride levels and that ApoA5 knockout mice had a 4-
fold increase in triglyceride concentrations compared
with control littermates [5]. Apo A5 is synthesized pri-
marily in the liver, and partially hepatectomized rats
showed up-regulated expression of Apo A5, further
indicating that Apo A5 may act by modulating the secre-
tion of lipids from the liver [7]. Another possibility is
that other functional mutation(s) may be present or
adjacent to the Apo A5 locus. It is more likely that 
the Apo A5 -1131T > C polymorphism is in linkage dis-
equilibrium with other causative mutations or nearby
genes involved in the metabolism of triglyceride mol-
ecules. Apo A5 is located approximately 27 kb distal
to the Apo A4 gene in the Apo A1/C3/A4 gene cluster
on chromosome 11 [5]. Linkage disequilibrium of the
-1131T > C polymorphism with other variants located
in Apo A5 have been studied previously. One recent
investigation in Taiwanese first showed a novel variant
of Apo A5, c.553 G > T, to be associated with hyper-
triglyceridemia [26]. The association was found to be
independent of all other Apo A5 genetic variants inves-
tigated in this study. Because the c.553 G > T polymor-
phic site is located in the translated region of the Apo
A5 gene, the subsequent amino acid change caused
by this polymorphism may further alter the regulation
of Apo A5 related to hypertriglyceridemia. Thus, it has
been suggested that it may serve as a prognostic indi-
cator for altered blood triglyceride levels [26]. Later,
Hsu et al [19] confirmed the associations of the c.553T
allele of the Apo A5 gene with hypertriglyceridemia,
as well as with coronary artery disease, in Taiwanese.
Haplotype analysis further indicated that subjects car-
rying a Apo A5 -1131C/c.553T bi-loci haplotype were
significantly overpresented among coronary artery
disease patients compared with control subjects, sug-
gesting that the -1131T>C polymorphism is possibly in
linkage disequilibrium with the c.553T polymorphism
and further causes hypertriglyceridemia. Furthermore,
linkage disequilibrium between variants in Apo A5 and
Apo C3 has also been reported. Talmud and colleagues
[27] included nine variants spanning the Apo C3/A4/
A5 cluster to determine the linkage disequilibrium
across the region and found the major triglyceride-
raising alleles to be the Apo A5 W19 and -482C > T
variants. They further indicated that the -1131T > C
variant of Apo A5 may be in strong linkage disequi-
librium with the -482C > T variant of Apo C3, and that
this linkage disequilibrium may subsequently lead to
functional changes. In our previous study, we found
that a common polymorphic site in Apo C3, -3238G
>C, was also associated with hypertriglyceridemia in
Paiwan and Amis Taiwanese aborigines [28]. How-
ever, Pennacchio et al [5,10] reported that the Apo
A5*2 haplotype represented by the -1131C allele of Apo
A5 was associated with elevation of serum triglyc-
erides in 500 unrelated Caucasian subjects, and this
association was independent of the Apo C3 -3238G > C
polymorphism.
In conclusion, our results indicate that the -1131T>C
polymorphism in the Apo A5 gene influences serum
triglyceride levels in female Taiwanese aborigines
and that the frequency of this minor allele is compa-
rable with that in other Asians, and higher than that
in Caucasians. Future studies designed to examine the
effect of the -1131C > T polymorphism on promoter
activity in vitro may facilitate further understanding
of the precise function of the -1131C genetic variant. In
addition, it is necessary to construct haplotypes using
multiple SNPs in the nearby genomic region to verify
whether this SNP is actually responsible for the al-
terations in serum triglyceride levels in this popula-
tion. Linkage disequilibrium between the polymorphic
site and the causative mutation can be strengthened
or weakened, and some of the discrepancies may 
be derived from genetic/environmental interactions.
Considering that Taiwanese aborigines have the high-
est prevalence of hypertriglyceridemia in seven areas
investigated in Taiwan [3] and possess a comparable
frequency of the Apo A5 -1131C allele to that reported in
Taiwanese [19], the interaction between environmental
Apolipoprotein A5 -1131T > C polymorphism
Kaohsiung J Med Sci April 2008 • Vol 24 • No 4 177
factors and Apo A5 -1131C-related variants warrants
further investigation.
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